P McManus

Summary

Affiliation: Therapeutic Goods Administration

Publications

  1. ncbi Antibiotic use in the Australian community, 1990-1995
    P McManus
    Drug Utilization Sub Committee, Department of Health and Family Services, Canberra, ACT
    Med J Aust 167:124-7. 1997
  2. ncbi Recent trends in the use of antidepressant drugs in Australia, 1990-1998
    P McManus
    Department of Health and Aged Care, Canberra, ACT
    Med J Aust 173:458-61. 2000
  3. ncbi Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia
    P McManus
    Drug Utilisation Sub Committee MDP 83, Department of Health and Aged Care, GPO Box 9848, Canberra ACT 2601, Australia
    Pharmacoepidemiol Drug Saf 10:295-300. 2001
  4. ncbi Use of antidepressants by general practitioners and psychiatrists in Australia
    Peter McManus
    Department of Health and Ageing, Canberra, Australian Capital Territory 2605, Australia
    Aust N Z J Psychiatry 37:184-9. 2003
  5. ncbi Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia
    Peter McManus
    Department of Health and Ageing, Canberra, ACT, Australia
    Aust N Z J Psychiatry 38:450-4. 2004
  6. ncbi Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee
    P McManus
    Department of Health and Family Services, Canberra
    Med J Aust 164:589-92. 1996
  7. ncbi Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries
    Fabrizio De Ponti
    Department of Pharmacology, University of Bologna, Bologna, Italy
    Br J Clin Pharmacol 54:171-7. 2002
  8. ncbi Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia
    BMJ 326:1008. 2003

Collaborators

Detail Information

Publications8

  1. ncbi Antibiotic use in the Australian community, 1990-1995
    P McManus
    Drug Utilization Sub Committee, Department of Health and Family Services, Canberra, ACT
    Med J Aust 167:124-7. 1997
    ..To determine the pattern of antibiotic use in the Australian community, 1990-1995, and compare it with the pattern in other developed countries...
  2. ncbi Recent trends in the use of antidepressant drugs in Australia, 1990-1998
    P McManus
    Department of Health and Aged Care, Canberra, ACT
    Med J Aust 173:458-61. 2000
    ..To determine the pattern of use of antidepressant drugs in the Australian community, 1990-1998, and to compare this with those of other developed countries...
  3. ncbi Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia
    P McManus
    Drug Utilisation Sub Committee MDP 83, Department of Health and Aged Care, GPO Box 9848, Canberra ACT 2601, Australia
    Pharmacoepidemiol Drug Saf 10:295-300. 2001
    ....
  4. ncbi Use of antidepressants by general practitioners and psychiatrists in Australia
    Peter McManus
    Department of Health and Ageing, Canberra, Australian Capital Territory 2605, Australia
    Aust N Z J Psychiatry 37:184-9. 2003
    ....
  5. ncbi Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia
    Peter McManus
    Department of Health and Ageing, Canberra, ACT, Australia
    Aust N Z J Psychiatry 38:450-4. 2004
    ....
  6. ncbi Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee
    P McManus
    Department of Health and Family Services, Canberra
    Med J Aust 164:589-92. 1996
    ..To determine the pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in the Australian community, 1990-1994...
  7. ncbi Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries
    Fabrizio De Ponti
    Department of Pharmacology, University of Bologna, Bologna, Italy
    Br J Clin Pharmacol 54:171-7. 2002
    ..The aim of this study was to assess the relevance and the magnitude of the problem in seven countries by grouping all nonantiarrhythmic drugs according to the type of evidence on QT prolongation and analysing their sales data...
  8. ncbi Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia
    BMJ 326:1008. 2003
    ..If so, increased prescribing of selective serotonin reuptake inhibitors in general practice may have produced a quantifiable benefit in population mental health...